Related Experiment Video
Updated: Aug 7, 2026

Isolation, Transfection, and Culture of Primary Human Monocytes
Published on: December 16, 2019
Therapeutic strategies towards HIV-1 infection in macrophages
Carlo Federico Perno1, Valentina Svicher, Dominique Schols
1National Institute for Infectious Diseases L. Spallanzani, Via Portuense 292, 00149 Rome, Italy. cf.perno@uniroma2.it
Abstract:
It is widely recognized that macrophages (M/M) represent a crucial target of HIV-1 in the body and play a pivotal role in the pathogenic progression of HIV-1 infection. This strongly supports the clinical relevance of therapeutic strategies able to interfere with HIV-1 replication in M/M. In vitro studies showed that nucleoside analogue inhibitors of HIV-1 reverse transcriptase have potent antiviral activity in M/M, although the limited penetration of these compounds in sequestered body compartments and low phosphorylation ability of M/M, suggest that a phosphonate group linked to NRTIs may confer greater anti-HIV-1 activity in M/M. Differently, the antiviral activity of non-nucleoside reverse transcriptase inhibitors in M/M is similar to that found in CD4+ lymphocytes. Interestingly, protease inhibitors, acting at a post-integrational stage of HIV-1 life-cycle are the only drugs active in chronically infected M/M. A careful analysis of the distribution of antiviral drugs, and the assessment of their activity in M/M, represent key factors in the development of therapeutic strategies aimed to the treatment of HIV-1-infected patients. Moreover, testing new and promising antiviral compounds in such cells may provide crucial hints about their efficacy in patients infected by HIV.
Insights
Macrophages are key targets for HIV-1. Understanding antiviral drug activity in macrophages is crucial for developing effective HIV therapies and improving patient outcomes.
Area of Science:
- Virology
- Immunology
- Pharmacology
Background:
- Macrophages (M/M) are critical targets of HIV-1, influencing disease progression.
- Therapeutic strategies targeting HIV-1 replication in M/M are clinically relevant.
Purpose of the Study:
- To evaluate the antiviral activity of different drug classes in macrophages.
- To inform the development of more effective HIV-1 treatment strategies.
Main Methods:
- In vitro studies assessing antiviral drug efficacy in macrophages.
- Analysis of drug penetration and phosphorylation in M/M.
Main Results:
- Nucleoside analogue reverse transcriptase inhibitors show potent activity but may benefit from phosphonate modification for M/M.
- Non-nucleoside reverse transcriptase inhibitors exhibit similar activity in M/M and CD4+ lymphocytes.
- Protease inhibitors are effective in chronically infected M/M.
Conclusions:
- Assessing drug distribution and activity in M/M is vital for HIV treatment development.
- Macrophages are important models for predicting antiviral efficacy in HIV-1 patients.
Related Concept Videos
Retrovirus Life Cycles
Inhibitors of Viral Protein Synthesis
Inhibitors of Virion Maturation and Assembly

